Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Education Control

Research Leaders

20 sponsors active, led by Duke University

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Unknown2
Recruiting1
Not Yet Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (5)

Showing 5 of 5 trials
NCT06982677Not ApplicableRecruitingPrimary

Improving Outcomes in Early Menopause After Cancer

NCT07100639Not Yet RecruitingPrimary

Singapore Population Research on Integrated exposoMe & Early Menopause

NCT03692572Not ApplicableCompletedPrimary

Influence of Early Menopause on Sympathetic Activation and Cardiovascular Function in Older Women

NCT05665010Unknown

Precise Stratification of Genetic Risk of Ovarian Function Impairment

NCT01411644Unknown

Pheno- & Genotyping POF (WHO III)

Showing all 5 trials

Research Network

Common Treatments

  • Education Control1
  • Genetic Susceptibility1
  • Nitrate Supplementation1
  • Nurse Navigator Intervention1

Active Sponsors

  • Duke University1
  • Academisch Ziekenhuis Maastricht1
  • Isala1
  • Department of Clinical Pharmacy, University Medical Centre St Radboud, The Netherlands.1
  • UMC Utrecht1

Top Investigators

Related Conditions

  • Cancer1
  • Premature Menopause1
  • Poor Response After Ovarian Hyperstimulation1
  • Premature Ovarian Failure Pof1
  • Diminished Ovarian Reserve1

Activity Timeline